although multivariable analyses were performed, residual confounding from unmeasured variables cannot be excluded
A randomized, double-blind, placebo-controlled phase 2 trial in Denmark involving 64 adults at high fracture risk found that once-weekly subcutaneous semaglutide did not increase the bone formation marker P-PINP relative to placebo, but did increase bone resorption and led to reductions in lumbar spine and hip BMD, tibial cortical thickness, and body weight over 52 weeks [104]
Punjab Univ J Zool 35(2):179189
Pierre-Louis: So theres been this big kind of tension brewing in recent months about the rise of what we might call imitation GLP-1s, like, the compounded versions
Due to secondary adrenal insufficiency, Hashimotos hypothyroidism, and other chronic health conditions, I take medications that promote weight gain, slow my metabolism, and make weight management an ongoing challenge
Once the catheter is removed in the office, many patients no longer need medication to manage prostate symptoms